I know this is a very simplistic assessment but here goes....

I know this is a very simplistic assessment but here goes.

jarden say 900m in earning in 10 years. If we assume a 10x earnings ratio this makes PEB a $9b company which is 18x where we are today (SP of about $13) Would anyone mind an 18 bagger?

so $900m NZD would require 840k tests per year at USA pricing. If the market is 5m test this requires about 17% of the market. So in the realms of possibilities.

From the latest presentation total lab throughput of commercial tests in USA is about 4,000 tests. For this to grow linear (unlikely as unpatriotic will be slow in the start) we need to increase 40,000 tests in the next 6 months which would provide revenue of about 30m in the next 6 months. I don’t see this happening. If it did even half of that I suggest the SP would increase significantly.